Apimeds Pharmaceuticals US (APUS) Change in Accured Expenses (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Change in Accured Expenses of $448494.0 for Q3 2025, up 296.45% on a YoY basis from $113128.0 in Q3 2024, and up 154.96% quarter-over-quarter from -$816064.0 in Q2 2025.
Apimeds Pharmaceuticals US (APUS) Change in Accured Expenses (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Change in Accured Expenses for 2 years, with the latest figure at $448494.0 in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses rose 296.45% year-over-year to $448494.0; the trailing twelve-month figure through Sep 2025 stood at $151675.0 (changed N/A YoY), and the FY2024 full-year result was $536752.0, up 904.48% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at $448494.0, up from -$816064.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $448494.0 in Q3 2025, with the low at -$816064.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 13.93 Mn | 10.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 448,494.00 |
| Sep 30, 2025 | 448,494.00 |
| Jun 30, 2025 | -816,064.00 |
| Jun 30, 2025 | -816,064.00 |
| Mar 31, 2025 | 344,012.00 |
| Mar 31, 2025 | 344,012.00 |
| Dec 31, 2024 | 175,233.00 |
| Dec 31, 2024 | 175,233.00 |
| Sep 30, 2024 | 113,128.00 |
| Sep 30, 2024 | 113,128.00 |
| Jun 30, 2024 | 243,184.00 |
| Jun 30, 2024 | 243,184.00 |
| Mar 31, 2024 | 5,207.00 |
| Mar 31, 2024 | 5,207.00 |